Zhao HT - Search Results

1

Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.

Huang C, Zhu XD, Shen YH, Xu B, Wu D, Ji Y, Chen LL, Song TQ, Zhang W, Zeng ZM, Huang HS, Wang K, Huang LQ, Chen YJ, Yang YC, Zhou LD, Long G, Zhao HT, Wang YC, Ge NL, Chen Y, Tan CJ, Zhou J, Fan J, Sun HC. Huang C, et al. Among authors: zhao ht. BMC Cancer. 2023 May 9;23(1):416. doi: 10.1186/s12885-023-10898-z. BMC Cancer. 2023. PMID: 37158833 Free PMC article.

2

[Comparison of different clinical staging systems for hepatocellular carcinoma].

Qu Q, Rui JA, Wang SB, Chen SG, Zhou L, Han K, Wei X, Zhang N, Zhao HT, Cheng EC. Qu Q, et al. Among authors: zhao ht. Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):155-8. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16750027 Chinese.

3

Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection.

Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY, Wei X, Han K, Zhang N, Zhao HT. Zhou L, et al. Among authors: zhao ht. J Surg Oncol. 2007 Mar 15;95(4):298-303. doi: 10.1002/jso.20678. J Surg Oncol. 2007. PMID: 17326130

4

Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy.

Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY, Wei X, Han K, Zhang N, Zhao HT. Zhou L, et al. Among authors: zhao ht. World J Surg. 2007 Sep;31(9):1782-1787. doi: 10.1007/s00268-007-9029-z. World J Surg. 2007. PMID: 17610113

5

[Early recurrence after the resection of hepatocellular carcinoma].

Lu X, Zhao HT, Mao YL, Sang XT, Xu YY, Du SD, Xu HF, Chi TY, Yang ZY, Zhong SX, Huang JF. Lu X, et al. Among authors: zhao ht. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):415-20. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008. PMID: 18795612 Chinese.

6

A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy.

Lu X, Zhao H, Yang H, Mao Y, Sang X, Miao R, Xu Y, Du S, Xu H, Chi T, Yang Z, Zhong S, Huang J. Lu X, et al. J Surg Oncol. 2009 Nov 1;100(6):488-93. doi: 10.1002/jso.21354. J Surg Oncol. 2009. PMID: 19653238

7

Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.

Miao RY, Zhao HT, Yang HY, Mao YL, Lu X, Zhao Y, Liu CN, Zhong SX, Sang XT, Huang JF. Miao RY, et al. Among authors: zhao y, zhao ht. World J Gastroenterol. 2010 Jun 21;16(23):2931-42. doi: 10.3748/wjg.v16.i23.2931. World J Gastroenterol. 2010. PMID: 20556841 Free PMC article.

8

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.

Mao Y, Yang H, Xu H, Lu X, Sang X, Du S, Zhao H, Chen W, Xu Y, Chi T, Yang Z, Cai J, Li H, Chen J, Zhong S, Mohanti SR, Lopez-Soler R, Millis JM, Huang J, Zhang H. Mao Y, et al. Gut. 2010 Dec;59(12):1687-93. doi: 10.1136/gut.2010.214916. Epub 2010 Sep 28. Gut. 2010. PMID: 20876776

9

[A survival analysis of patients with early-stage hepatocellular carcinoma fulfilling Milan criteria and undergoing hepatectomy].

Liu LG, Miao RY, Lu X, Xu YY, Du SD, Xu HF, Chi TY, Yang HY, Yang ZY, Mao YL, Sang XT, Zhong SX, Huang JF, Zhao HT. Liu LG, et al. Among authors: zhao ht. Zhonghua Yi Xue Za Zhi. 2010 Dec 14;90(46):3251-4. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21223780 Chinese.

10

Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China.

Liu L, Miao R, Yang H, Lu X, Zhao Y, Mao Y, Zhong S, Huang J, Sang X, Zhao H. Liu L, et al. Am J Surg. 2012 Jun;203(6):741-50. doi: 10.1016/j.amjsurg.2011.05.010. Epub 2011 Dec 15. Am J Surg. 2012. PMID: 22177551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page